These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25187909)

  • 1. Influenza Research & Development - GTCBio's Third Annual Conference (July 9-11 - Boston, Massachusetts, USA, 2014).
    Tompkins SM
    Drugs Today (Barc); 2014 Aug; 50(8):599-605. PubMed ID: 25187909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.
    Rudenko L; Yeolekar L; Kiseleva I; Isakova-Sivak I
    Vaccine; 2016 Oct; 34(45):5436-5441. PubMed ID: 27593158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. World Vaccine Congress Lyon - Terrapinn's 11th Annual Congress.
    Sovran L
    IDrugs; 2009 Dec; 12(12):738-41. PubMed ID: 19943212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.
    Girard MP; Katz JM; Pervikov Y; Hombach J; Tam JS
    Vaccine; 2011 Oct; 29(44):7579-86. PubMed ID: 21856358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for seasonal and pandemic influenza.
    Nichol KL; Treanor JJ
    J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
    Isakova-Sivak I; Rudenko L
    Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live attenuated vaccines for pandemic influenza.
    Chen GL; Subbarao K
    Curr Top Microbiol Immunol; 2009; 333():109-32. PubMed ID: 19768402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.
    Prosper O; Saucedo O; Thompson D; Torres-Garcia G; Wang X; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):141-70. PubMed ID: 21361405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
    Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
    Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus.
    Rudenko L; Isakova-Sivak I
    Expert Rev Vaccines; 2015 Mar; 14(3):395-412. PubMed ID: 25555687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trials for influenza drugs and vaccines: a review of controlled human infection studies.
    Balasingam S; Wilder-Smith A
    Int J Infect Dis; 2016 Aug; 49():18-29. PubMed ID: 27208631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial.
    Kwong JC; Pereira JA; Quach S; Pellizzari R; Dusome E; Russell ML; Hamid JS; Feinberg Y; Winter AL; Gubbay JB; Sirtonski B; Moher D; Sider D; Finkelstein M; Loeb M;
    Vaccine; 2015 Jan; 33(4):535-41. PubMed ID: 25488331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza in Older Adults.
    Talbot HK
    Infect Dis Clin North Am; 2017 Dec; 31(4):757-766. PubMed ID: 28911829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third European Influenza Summit: organized by the European Scientific Working group on Influenza (ESWI).
    McElhaney J; Osterhaus A
    Vaccine; 2013 Dec; 31(52):6161-7. PubMed ID: 24183711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terrapinn's world influenza congress Europe 2009. Part 1.
    Veryard C
    IDrugs; 2010 Feb; 13(2):76-7. PubMed ID: 20127555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terrapinn's world influenza congress Europe 2009. Part 2.
    Veryard C
    IDrugs; 2010 Feb; 13(2):78-9. PubMed ID: 20127556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine Manufacturing--Second Annual visiongain Conference.
    McPherson C
    IDrugs; 2010 Jul; 13(7):437-9. PubMed ID: 20582865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials: World Health Organization, Geneva, Switzerland, 12-13 February 2009.
    Hayden FG; Howard WA; Palkonyay L; Kieny MP
    Vaccine; 2009 Jun; 27(31):4079-89. PubMed ID: 19406184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.
    Poland GA; Fleming DM; Treanor JJ; Maraskovsky E; Luke TC; Ball EM; Poland CM
    Vaccine; 2013 Apr; 31 Suppl 1():A1-20. PubMed ID: 23587330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.